Summary of Clarivate's Q4 2025 Earnings Call

1Key Financial Results and Metrics

Q4 Revenue: $617 million; Full Year Revenue: $2.455 billion (entirely inorganic due to divestitures).

Net Income: $3 million for Q4, a $195 million improvement year-over-year; Full Year Improvement: $436 million, driven by the absence of prior year impairment charges.

Adjusted EBITDA: Over $1 billion for the year; Free Cash Flow: $365 million, representing a 2% increase year-over-year.

Organic Annual Contract Value (ACV) Growth: Nearly 2% in 2025, with 88% of revenue from organic recurring sources.

Retention Rate: Stable at 93%.

2Strategic Updates and Business Highlights

Clarivate is undergoing a strategic review and has initiated a process to sell its Life Sciences & Health (LS&H) business to focus on Academia & Government (A&G) and Intellectual Property (IP) segments.

The company has launched 12 major AI-powered products and features, enhancing its market position.

AI is viewed as an amplifier of business capabilities rather than a disruption, with 97% of revenue derived from proprietary solutions.

The A&G segment achieved 2% organic ACV growth despite funding headwinds, while the IP segment is expected to return to growth with new leadership and product innovations.

3Forward Guidance and Outlook

2026 Guidance:

Organic ACV growth projected at 2% to 3%.

Recurring organic revenue growth targeted at 1% to 2%.

Free cash flow expected to grow to approximately $400 million (10% increase).

The company anticipates continued improvement in operational metrics, with a focus on innovation and portfolio rationalization.

4Bad News, Challenges, or Points of Concern

The company faces challenges from the ongoing divestiture process, which is expected to lower revenue by approximately $100 million in 2026.

Organic transactional revenues have declined, impacting overall revenue growth.

There are concerns regarding AI disruption in the software and information services sector, although management believes their proprietary data and solutions provide a competitive moat.

5Notable Q&A Insights

Monetization Model: The subscription model remains varied, with a mix of seat licenses and institutional size influencing pricing. AI innovations are seen as potential upsell opportunities.

IP Segment Recovery: Management expressed confidence in returning the IP segment to growth, citing new product launches and market recovery indicators.

Capital Allocation: The company plans to prioritize deleveraging over stock buybacks, despite attractive free cash flow returns, due to a favorable debt structure and market conditions.

Price Realization: Growth in ACV and recurring revenue is primarily driven by volume rather than price increases, with expectations for continued volume-driven growth in 2026. Overall, Clarivate is positioned for growth through strategic focus on its core segments and leveraging AI innovations, despite facing challenges from divestitures and market dynamics.